TEST BANK For Pharmacotherapeutics for Advanced Practice Nurse Prescribers 5th Edition by Teri Moser Woo & Marylou V. Robinson , ISBN: 9780803669260 |All Chapters 1-55 Complete| Guide A+

Pharmacotherapeutics for Advanced Practice Nurse Prescribers 5th Edition Woo & Robinson Test Bank UNIT I. THEWoo & Robinson1. The Role of the Nurse Practitioner as Prescriber Chapter 2. Review of the Basic Principles of Pharmacology Chapter 3. Rational Drug Selection Chapter 4. Legal and Professional Issues in Prescribing Chapter 5. Adverse Drug Reactions Chapter 6. An Introduction to Pharmacogenetics Chapter 7. Nutrition and Neutraceuticals Chapter 8. Herbal Therapies and Cannabis Chapter 9. Information Technology and Pharmacotherapeutics Chapter 10. Pharmacoeconomics UNIT II. PHARMACOTHERAPEUTICS WITH SINGLE DRUGS Chapter 11. Drugs Affecting the Autonomic Nervous System Chapter 12. Drugs Affecting the Central Nervous System Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems Chapter 14. Drugs Affecting the Respiratory System Chapter 15. Drugs Affecting the Hematological System Chapter 16. Drugs Affecting the Immune System Chapter 17. Drugs Affecting the Gastrointestinal System Chapter 18. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs Chapter 19. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs Chapter 20. Drugs Affecting the Reproductive System Chapter 21. Drugs Affecting the Bones and Joints Chapter 22. Drugs Affecting the Integumentary System Chapter 23. Drugs Used to Treat Bacterial Infections Chapter 24. Drugs Used to Treat Viral, Fungal, and Protozoal Infections Chapter 25. Drugs Used to Treat Inflammatory Processes Chapter 26. Drugs Used to Treat Eye and Ear Disorders UNIT III. PHARMACOTHERAPEUTICS WITH MULTIPLE DRUGS Chapter 27. Alcohol and Drug Addiction Chapter 28. Anemia Chapter 29. Angina Chapter 30. Anxiety and Depression Chapter 31. Attention Deficit Hyperactivity Disorder Chapter 32. Asthma and Chronic Obstructive Pulmonary Disease Chapter 33. Contraception Chapter 34. Dermatological Conditions Chapter 35. Diabetes Management Chapter 36. Gastroesophageal Reflux and Peptic Ulcer Disease Chapter 37. Headaches Chapter 38. Heart Failure Chapter 39. Human Immunodeficiency Virus Disease and Acquired Immunodeficiency Syndrome Chapter 40. Hormone Replacement Therapy Chapter 41. Hyperlipidemia Chapter 42. Hypertension Chapter 43. Hyperthyroidism and Hypothyroidism Chapter 44. Pain Management: Acute and Chronic Pain Chapter 45. Pneumonia Chapter 46. Tobacco Cessation Chapter 47. Sexually Transmitted Diseases and Vaginitis Chapter 48. Tuberculosis Chapter 49. Upper Respiratory Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa Chapter 50. Urinary Tract Infection UNIT IV. SPECIAL DRUG TREATMENT CONSIDERATIONS Chapter 51. Women as Patients Chapter 52. Men as Patients Chapter 53. Pediatric Patients Chapter 54. Transgendered Clients as Patients Chapter 55. Geriatric Patients Unit I. The Foundation Chapter 1. The Role of the Nurse Practitioner as Prescriber Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Nurse practitioner prescriptive authority is regulated by: 1. The National Council of State Boards of Nursing 2. The U.S. Drug Enforcement Administration 3. The State Board of Nursing for each state 4. The State Board of Pharmacy 2. The benefits to the patient of having an Advanced Practice Registered Nurse (APRN) prescriber include: 1. Nurses know more about Pharmacology than other prescribers because they take it both in their basic nursing program and in their APRN program. 2. Nurses care for the patient from a holistic approach and include the patient in decision making regarding their care. 3. APRNs are less likely to prescribe narcotics and other controlled substances. 4. APRNs are able to prescribe independently in all states, whereas a physician’s assistant needs to have a physician supervising their practice. 3. Clinical judgment in prescribing includes: 1. Factoring in the cost to the patient of the medication prescribed 2. Always prescribing the newest medication available for the disease process 3. Handing out drug samples to poor patients 4. Prescribing all generic medications to cut costs 4. Criteria for choosing an effective drug for a disorder include: 1. Asking the patient what drug they think would work best for them 2. Consulting nationally recognized guidelines for disease management 3. Prescribing medications that are available as samples before writing a prescription 4. Following U.S. Drug Enforcement Administration guidelines for prescribing 5. Nurse practitioner practice may thrive under health-care reform because of: 1. The demonstrated ability of nurse practitioners to control costs and improve patient outcomes 2. The fact that nurse practitioners will be able to practice independently 3. The fact that nurse practitioners will have full reimbursement under health-care reform 4. The ability to shift accountability for Medicaid to the state level Chapter 1. The Role of the Nurse Practitioner Answer Section MULTIPLE CHOICE 1. ANS: 3 PTS: 1 2. ANS: 2 PTS: 1 3. ANS: 1 PTS: 1 4. ANS: 2 PTS: 1 5. ANS: 1 PTS: 1 Chapter 2. Review of Basic Principles of Pharmacology Multiple Choice Identify the choice that best completes the statement or answers the question. 1. A patient’s nutritional intake and laboratory results reflect hypoalbuminemia. This is critical to prescribing because: 1. Distribution of drugs to target tissue may be affected. 2. The solubility of the drug will not match the site of absorption. 3. There will be less free drug available to generate an effect. 4. Drugs bound to albumin are readily excreted by the kidneys. 2. Drugs that have a significant first-pass effect: 1. Must be given by the enteral (oral) route only 2. Bypass the hepatic circulation 3. Are rapidly metabolized by the liver and may have little if any desired action 4. Are converted by the liver to more active and fat-soluble forms 3. The route of excretion of a volatile drug will likely be the: 1. Kidneys 2. Lungs 3. Bile and feces 4. Skin 4. Medroxyprogesterone (Depo Provera) is prescribed intramuscularly (IM) to create a storage reservoir of the drug. Storage reservoirs: 1. Assure that the drug will reach its intended target tissue 2. Are the reason for giving loading doses 3. Increase the length of time a drug is available and active 4. Are most common in collagen tissues 5. The NP chooses to give cephalexin every 8 hours based on knowledge of the drug’s: 1. Propensity to go to the target receptor 2. Biological half-life 3. Pharmacodynamics 4. Safety and side effects 6. Azithromycin dosing requires that the first day’s dosage be twice those of the other 4 days of the prescription. This is considered a loading dose. A loading dose: 1. Rapidly achieves drug levels in the therapeutic range 2. Requires four- to five-half-lives to attain 3. Is influenced by renal function 4. Is directly related to the drug circulating to the target tissues 7. The point in time on the drug concentration curve that indicates the first sign of a therapeutic effect is the: 1. Minimum adverse effect level 2. Peak of action 3. Onset of action 4. Therapeutic range 8. Phenytoin requires that a trough level be drawn. Peak and trough levels are done: 1. When the drug has a wide therapeutic range 2. When the drug will be administered for a short time only 3. When there is a high correlation between the dose and saturation of receptor sites 4. To determine if a drug is in the therapeutic range 9. A laboratory result indicates that the peak level for a drug is above the minimum toxic concentration. This means that the: 1. Concentration will produce therapeutic effects 2. Concentration will produce an adverse response 3. Time between doses must be shortened 4. Duration of action of the drug is too long 10. Drugs that are receptor agonists may demonstrate what property? 1. Irreversible binding to the drug receptor site 2. Upregulation with chronic use 3. Desensitization or downregulation with continuous use 4. Inverse relationship between drug concentration and drug action 11. Drugs that are receptor antagonists, such as beta blockers, may cause: 1. Downregulation of the drug receptor 2. An exaggerated response if abruptly discontinued 3. Partial blockade of the effects of agonist drugs 4. An exaggerated response to competitive drug agonists 12. Factors that affect gastric drug absorption include: 1. Liver enzyme activity 2. Protein-binding properties of the drug molecule 3. Lipid solubility of the drug 4. Ability to chew and swallow 13. Drugs administered via IV: 1. Need to be lipid soluble in order to be easily absorbed 2. Begin distribution into the body immediately 3. Are easily absorbed if they are nonionized 4. May use pinocytosis to be absorbed 14. When a medication is added to a regimen for a synergistic effect, the combined effect of the drugs is: 1. The sum of the effects of each drug individually 2. Greater than the sum of the effects of each drug individually 3. Less than the effect of each drug individually 4. Not predictable, as it varies with each individual 15. Which of the following statements about bioavailability is true? 1. Bioavailability issues are especially important for drugs with narrow therapeutic ranges or sustained-release mechanisms. 2. All brands of a drug have the same bioavailability. 3. Drugs that are administered more than once a day have greater bioavailability than drugs given once daily. 4. Combining an active drug with an inert substance does not affect bioavailability. 16. Which of the following statements about the major distribution barriers (blood-brain or fetal-placental) is true? 1. Water soluble and ionized drugs cross these barriers rapidly. 2. The blood-brain barrier slows the entry of many drugs into and from brain cells. 3. The fetal-placental barrier protects the fetus from drugs taken by the mother. 4. Lipid-soluble drugs do not pass these barriers and are safe for pregnant women. 17. Drugs are metabolized mainly by the liver via phase I or phase II reactions. The purpose of both of these types of reactions is to: 1. Inactivate prodrugs before they can be activated by target tissues 2. Change the drugs so they can cross plasma membranes 3. Change drug molecules to a form that an excretory organ can excrete 4. Make these drugs more ionized and polar to facilitate excretion 18. Once they have been metabolized by the liver, the metabolites may be: 1. More active than the parent drug 2. Less active than the parent drug 3. Totally “deactivated” so they are excreted without any effect 4. All of the above 19. All drugs continue to act in the body until they are changed or excreted. The ability of the body to excrete drugs via the renal system would be increased by: 1. Reduced circulation and perfusion of the kidney 2. Chronic renal disease 3. Competition for a transport site by another drug 4. Unbinding a nonvolatile drug from plasma proteins 20. Steady state is: 1. The point on the drug concentration curve when absorption exceeds excretion 2. When the amount of drug in the body remains constant 3. When the amount of drug in the body stays below the minimum toxic concentration 4. All of the above 21. Two different pain medications are given together for pain relief. The drug—drug interaction is: 1. Synergistic 2. Antagonistic 3. Potentiative 4. Additive 22. Actions taken to reduce drug—drug interaction problems include all of the following EXCEPT: 1. Reducing the dosage of one of the drugs 2. Scheduling their administration at different times 3. Prescribing a third drug to counteract the adverse reaction of the combination 4. Reducing the dosage of both drugs 23. Phase I oxidative-reductive processes of drug metabolism require certain nutritional elements. Which of the following would reduce or inhibit this process? 1. Protein malnutrition 2. Iron-deficiency anemia 3. Both 1 and 2 4. Neither 1 nor 2 24. The time required for the amount of drug in the body to decrease by 50% is called: 1. Steady state 2. Half-life 3. Phase II metabolism 4. Reduced bioavailability time 25. An agonist activates a receptor and stimulates a response. When given frequently over time, the body may: 1. Upregulate the total number of receptors 2. Block the receptor with a partial agonist 3. Alter the drug’s metabolism 4. Downregulate the numbers of that specific receptor 26. Drug antagonism is best defined as an effect of a drug that: 1. Leads to major physiological and psychological dependence 2. Is modified by the concurrent administration of another drug 3. Cannot be metabolized before another dose is administered 4. Leads to a decreased physiological response when combined with another drug 27. Instructions to a client regarding self-administration of oral enteric-coated tablets should include which of the following statements? 1. “Avoid any other oral medicines while taking this drug.” 2. “If swallowing this tablet is difficult, dissolve it in 3 ounces of orange juice.” 3. “The tablet may be crushed if you have any difficulty taking it.” 4. “To achieve best effect, take the tablet with at least 8 ounces of fluid.” 28. The major reason for not crushing a sustained-release capsule is that, if crushed, the coated beads of the drugs could possibly result in: 1. Disintegration 2. Toxicity 3. Malabsorption 4. Deterioration 29. Which of the following substances is the most likely to be absorbed in the intestines rather than in the stomach? 1. Sodium bicarbonate 2. Ascorbic acid 3. Salicylic acid 4. Glucose 30. Which of the following variables is a factor in drug absorption? 1. The smaller the surface area for absorption, the more rapidly the drug is absorbed. 2. A rich blood supply to the area of absorption leads to better absorption. 3. The less soluble the drug, the more easily it is absorbed. 4. Ionized drugs are easily absorbed across the cell membrane. 31. An advantage of prescribing a sublingual medication is that the medication is: 1. Absorbed rapidly 2. Excreted rapidly 3. Metabolized minimally 4. Distributed equally 32. Drugs that use CYP 3A4 isoenzymes for metabolism may: 1. Induce the metabolism of another drug 2. Inhibit the metabolism of another drug 3. Both 1 and 2 4. Neither 1 nor 2 33. Therapeutic drug levels are drawn when a drug reaches steady state. Drugs reach steady state: 1. After the second dose 2. After four to five half-lives 3. When the patient feels the full effect of the drug 4. One hour after IV administration 34. Upregulation or hypersensitization may lead to: 1. Increased response to a drug 2. Decreased response to a drug 3. An exaggerated response if the drug is withdrawn 4. Refractoriness or complete lack of response Chapter 2. Review of Basic Principles of Pharmacology Answer Section MULTIPLE CHOICE 1. ANS 1 PTS: 1 : 2. ANS 3 PTS: 1 : 3. ANS 2 PTS: 1 : 4. ANS 3 PTS: 1 : 5. ANS 2 PTS: 1 : 6. ANS 1 PTS: 1 : 7. ANS 3 PTS: 1 : 8. ANS 4 PTS: 1 : 9. ANS 2 PTS: 1 : 10. ANS 3 PTS: 1 : 11. ANS 2 PTS: 1 : 12. ANS 3 PTS: 1 : 13. ANS 2 PTS: 1 : 14. ANS 2 PTS: 1 : 15. ANS 1 PTS: 1 : 16. ANS 2 PTS: 1 : 17. ANS 3 PTS: 1 : 18. ANS 4 PTS: 1 : 19. ANS 4 PTS: 1 : 20. ANS 2 PTS: 1 : 21. ANS 4 PTS: 1 : 22. ANS 3 PTS: 1 : 23. ANS 4 PTS: 1 : 24. ANS 2 PTS: 1 : 25. ANS 4 PTS: 1 : 26. ANS 2 PTS: 1 : 27. ANS 4 PTS: 1 : 28. ANS 2 PTS: 1 : 29. ANS 1 PTS: 1 : 30. ANS 2 PTS: 1 : 31. ANS 1 PTS: 1 : 32. ANS 3 PTS: 1 : 33. ANS 2 PTS: 1 34. : ANS 3 PTS: 1 : Chapter 3. Rational Drug Selection Multiple Choice Identify the choice that best completes the statement or answers the question. 1. An NP would prescribe the liquid form of ibuprofen for a 6-year-old child because: 1. Drugs given in liquid form are less irritating to the stomach. 2. A 6-year-old child may have problems swallowing a pill. 3. Liquid forms of medication eliminate the concern for first-pass effect. 4. Liquid ibuprofen does not have to be dosed as often as the tablet form. 2. In deciding which of multiple drugs used to use to treat a condition, the NP chooses Drug A because it: 1. Has serious side effects and it is not being used for a life-threatening condition 2. Will be taken twice daily and will be taken at home 3. Is expensive, but covered by health insurance 4. None of these are important in choosing a drug 3. A client asks the NP about the differences in drug effects between men and women. What is known about the differences between the pharmacokinetics of men and women? 1. Body temperature varies between men and women. 2. Muscle mass is greater in women. 3. Percentage of fat differs between genders. 4. Proven subjective factors exist between the genders. 4. The first step in the prescribing process according to the World Health Organization is: 1. Choosing the treatment 2. Educating the patient about the medication 3. Diagnosing the patient’s problem 4. Starting the treatment 5. Treatment goals in prescribing should: 1. Always be curative 2. Be patient-centered 3. Be convenient for the provider 4. Focus on the cost of therapy 6. The therapeutic goals when prescribing include(s): 1. Curative 2. Palliative 3. Preventive 4. All of the above 7. When determining drug treatment the NP prescriber should: 1. Always use evidence-based guidelines 2. Individualize the drug choice for the specific patient 3. Rely on his or her experience when prescribing for complex patients 4. Use the newest drug on the market for the condition being treated 8. Patient education regarding prescribed medication includes: 1. Instructions written at the high school reading level 2. Discussion of expected adverse drug reactions 3. How to store leftover medication such as antibiotics 4. Verbal instructions always in English 9. Passive monitoring of drug effectiveness includes: 1. Therapeutic drug levels 2. Adding or subtracting medications from the treatment regimen 3. Ongoing provider visits 4. Instructing the patient to report if the drug is not effective 10. Pharmacokinetic factors that affect prescribing include: 1. Therapeutic index 2. Minimum effective concentration 3. Bioavailability 4. Ease of titration 11. Pharmaceutical promotion may affect prescribing. To address the impact of pharmaceutical promotion, the following recommendations have been made by the Institute of Medicine: 1. Conflicts of interest and financial relationships should be disclosed by those providing education. 2. Providers should ban all pharmaceutical representatives from their office setting. 3. Drug samples should be used for patients who have the insurance to pay for them, to ensure the patient can afford the medication. 4. Providers should only accept low-value gifts, such as pens and pads of paper, from the pharmaceutical representative. 12. Under new U.S. Food and Drug Administration labeling, Pregnancy Categories will be: 1. Strengthened with a new coding such as C+ or C- to discern when a drug is more or less toxic to the fetus 2. Changed to incorporate a pregnancy risk summary and clinical considerations on the drug label 3. Eliminated, and replaced with a link to the National Library of Medicine TOXNET Web site for in-depth information regarding pregnancy concerns 4. Clarified to include information such as safe dosages in each trimester of pregnancy Chapter 3. Rational Drug Selection Answer Section MULTIPLE CHOICE 1. ANS: 2 PTS: 1 2. ANS: 2 PTS: 1 3. ANS: 3 PTS: 1 4. ANS: 3 PTS: 1 5. ANS: 2 PTS: 1 6. ANS: 4 PTS: 1 7. ANS: 2 PTS: 1 8. ANS: 2 PTS: 1 9. ANS: 4 PTS: 1 10. ANS: 3 PTS: 1 11. ANS: 1 PTS: 1 12. ANS: 2 PTS: 1 Chapter 4. Legal and Professional Issues in Prescribing Multiple Choice Identify the choice that best completes the statement or answers the question. 1. The U.S. Food and Drug Administration regulates: 1. Prescribing of drugs by MDs and NPs 2. The official labeling for all prescription and over-the-counter drugs 3. Off-label recommendations for prescribing 4. Pharmaceutical educational offerings 2. The U.S. Food and Drug Administration approval is required for: 1. Medical devices, including artificial joints 2. Over-the-counter vitamins 3. Herbal products, such as St John’s wort 4. Dietary supplements, such as Ensure 3. An Investigational New Drug is filed with the U.S. Food and Drug Administration: 1. When the manufacturer has completed phase III trials 2. When a new drug is discovered 3. Prior to animal testing of any new drug entity 4. Prior to human testing of any new drug entity 4. Phase IV clinical trials in the United States are also known as: 1. Human bioavailability trials 2. Postmarketing research 3. Human safety and efficacy studies 4. The last stage of animal trials before the human trials begin 5. Off-label prescribing is: 1. Regulated by the U.S. Food and Drug Administration 2. Illegal by NPs in all states (provinces) 3. Legal if there is scientific evidence for the use 4. Regulated by the Drug Enforcement Administration 6. The U.S. Drug Enforcement Administration: 1. Registers manufacturers and prescribers of controlled substances 2. Regulates NP prescribing at the state level 3. Sanctions providers who prescribe drugs off-label 4. Provides prescribers with a number they can use for insurance billing 7. Drugs that are designated Schedule II by the U.S. Drug Enforcement Administration: 1. Are known teratogens during pregnancy 2. May not be refilled; a new prescription must be written 3. Have a low abuse potential 4. May be dispensed without a prescription unless regulated by the state 8. Precautions that should be taken when prescribing controlled substances include: 1. Faxing the prescription for a Schedule II drug directly to the pharmacy 2. Using tamper-proof paper for all prescriptions written for controlled drugs 3. Keeping any pre-signed prescription pads in a locked drawer in the clinic 4. Using only numbers to indicate the amount of drug to be prescribed 9. Strategies prescribers can use to prevent misuse of controlled prescription drugs include: 1. Use of chemical dependency screening tools 2. Firm limit-setting regarding prescribing controlled substances 3. Practicing “just say no” to deal with patients who are pushing the provider to prescribe controlled substances 4. All of the above 10. Behaviors predictive of addiction to controlled substances include: 1. Stealing or borrowing another patient’s drugs 2. Requiring increasing doses of opiates for pain associated with malignancy 3. Receiving refills of a Schedule II prescription on a regular basis 4. Requesting that only their own primary care provider prescribe for them 11. Medication agreements or “Pain Medication Contracts” are recommended to be used: 1. Universally for all prescribing for chronic pain 2. For patients who have repeated requests for pain medication 3. When you suspect a patient is exhibiting drug-seeking behavior 4. For patients with pain associated with malignancy 12. A prescription needs to be written for: 1. Legend drugs 2. Most controlled drugs 3. Medical devices 4. All of the above Chapter 4. Legal and Professional Issues in Prescribing Answer Section MULTIPLE CHOICE Chapter 5. Adverse Drug Reactions Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Which of the following patients would be at higher risk of experiencing adverse drug reactions (ADRs): 1. A 32-year-old male 2. A 22-year-old female 3. A 3-month-old female 4. A 48-year-old male 2. Infants and young children are at higher risk of ADRs due to: 1. Immature renal function in school-age children 2. Lack of safety and efficacy studies in the pediatric population 3. Children’s skin being thicker than adults, requiring higher dosages of topical medication 4. Infant boys having a higher proportion of muscle mass, leading to a higher volume of distribution 3. The elderly are at high risk of ADRs due to: 1. Having greater muscle mass than younger adults, leading to higher volume of distribution 2. The extensive studies that have been conducted on drug safety in this age group 3. The blood-brain barrier being less permeable, requiring higher doses to achieve therapeutic effect 4. Age-related decrease in renal function 4. The type of adverse drug reaction that is idiosyncratic when a drug given in the usual therapeutic doses is type: 1. A 2. B 3. C 4. D 5. Digoxin may cause a type A adverse drug reaction due to: 1. Idiosyncratic effects 2. Its narrow therapeutic index 3. Being a teratogen 4. Being a carcinogen 6. Sarah developed a rash after using a topical medication. This is a type allergic drug reaction. 1. I 2. II 3. III 4. IV 7. A patient may develop neutropenia from using topical Silvadene for burns. Neutropenia is a(n): 1. Cytotoxic hypersensitivity reaction 2. Immune complex hypersensitivity 3. Immediate hypersensitivity reaction 4. Delayed hypersensitivity reaction 8. Anaphylactic shock is a: 1. Type I reaction, called immediate hypersensitivity reaction 2. Type II reaction, called cytotoxic hypersensitivity reaction 3. Type III allergic reaction, called immune complex hypersensitivity 4. Type IV allergic reaction, called delayed hypersensitivity reaction 9. James has hypothalamic-pituitary-adrenal axis suppression from chronic prednisone (a corticosteroid) use. He is at risk for what type of adverse drug reaction? 1. Type B 2. Type C 3. Type E 4. Type F 10. Immunomodulators such as azathioprine may cause a delayed adverse drug reaction known as a type D reaction because they are known: 1. Teratogens 2. Carcinogens 3. To cause hypersensitivity reactions 4. Hypothalamus-pituitary-adrenal axis suppressants 11. A 24-year-old male received multiple fractures in a motor vehicle accident that required significant amounts of opioid medication to treat his pain. He is at risk for a adverse drug reaction when he no longer requires the opioids. 1. Rapid 2. First-dose 3. Late 4. Delayed 12. An example of a first-dose reaction that may occur includes: 1. Orthostatic hypotension that does not occur with repeated doses 2. Purple glove syndrome with phenytoin use 3. Hemolytic anemia from ceftriaxone use 4. Contact dermatitis from neomycin use 13. Drugs that are prone to cause adverse drug effects include: 1. Diuretics 2. Inhaled anticholinergics 3. Insulins 4. Stimulants 14. The U.S. Food and Drug Administration MedWatch system is activated when: 1. There is an adverse event to a vaccine. 2. The patient has a severe reaction that is noted in the “Severe Reaction” section in the medication label. 3. A lactating woman takes a medication that is potentially toxic to the breastfeeding infant. 4. An adverse event or serious problem occurs with a medication that is not already identified on the label. 15. The Vaccine Adverse Events Reporting System is: 1. A mandatory reporting system for all health-care providers when they encounter an adverse vaccine event 2. A voluntary reporting system that health-care providers or consumers may use to report vaccine adverse events 3. Utilized to send out safety alerts regarding emerging vaccine safety issues 4. Activated when a vaccine has been proven to cause significant adverse effects Chapter 5. Adverse Drug Reactions Answer Section MULTIPLE CHOICE 1. ANS: 3 PTS: 1 2. ANS: 2 PTS: 1 3. ANS: 4 PTS: 1 4. ANS: 2 PTS: 1 5. ANS: 2 PTS: 1 6. ANS: 4 PTS: 1 7. ANS: 1 PTS: 1 8. ANS: 1 PTS: 1 9. ANS: 2 PTS: 1 10. ANS: 2 PTS: 1 11. ANS: 3 PTS: 1 12. ANS: 1 PTS: 1 13. ANS: 3 PTS: 1 14. ANS: 4 PTS: 1 15. ANS: 2 PTS: 1 Chapter 6. Pharmacoeconomics Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Pharmacoeconomics is: 1. The study of the part of the U.S. economy devoted to drug use 2. The study of the impact of prescription drug costs on the overall economy 3. The analysis of the costs and consequences of any health-care-related treatment or service 4. The analysis of the clinical efficacy of the drug 2. The direct costs of drug therapy include: 1. The actual cost of acquiring the medication 2. The loss of income due to illness 3. Pain and suffering due to inadequate drug therapy 4. The cost of a funeral associated with premature death 3. Indirect costs associated with drug therapy include: 1. The cost of diagnostic tests to monitor therapeutic levels 2. Health-care provider time to prescribe and educate the patient 3. Child-care expenses incurred while receiving therapy 4. Loss of wages while undergoing drug therapy 4. The intangible costs of drug therapy include: 1. Loss of wages while undergoing therapy 2. Inconvenience, pain, and suffering incurred with therapy 3. Cost of medical equipment in the laboratory used to monitor therapeutic drug levels 4. Cost of prescription drug coverage, such as Medicare Part D 5. When a pharmacoeconomic analysis looks at two or more treatment alternatives that are considered equal in efficacy and compares the costs of each it is referred to as: 1. Cost-minimization analysis 2. Cost-of-illness analysis 3. Cost-effectiveness analysis 4. Cost-benefit analysis 6. Cost-effectiveness analysis compares two or more treatments or programs that are: 1. Not necessarily therapeutically equivalent 2. Considered equal in efficacy 3. Compared with the dollar value of the benefit received 4. Expressed in terms of patient preference or quality-adjusted life years 7. When the costs of a specific treatment or intervention are calculated and then compared with the dollar value of the benefit received it is referred to as: 1. Cost-minimization analysis 2. Cost-of-illness analysis 3. Cost-effectiveness analysis 4. Cost-benefit analysis 8. Mary has a two-tiered prescription benefit plan, which means: 1. She can receive differing levels of care based on whether she chooses an “in-plan” provider or not. 2. She is eligible for the new Medicare Part D “donut hole” reduction of costs program. 3. She pays a higher copay for brand-name drugs than for generic drugs. 4. She must always choose to be treated with generic drugs first. 9. Prescribing less-expensive generic drugs or drugs off the $4 retail pharmacy lists: 1. Increases the complexity of the pharmacoeconomics of prescribing for the individual patient 2. Increases compliance by reducing the financial burden of drug costs to the patient 3. Is not sound prescribing practice due to the inferiority of the generic products 4. Will increase the overall cost of drugs to the system due to the ease of overprescribing less-expensive drugs 10. James tells you that he is confused by his Medicare Part D coverage plan. An appropriate intervention would be: 1. Order cognitive testing to determine the source of his confusion. 2. Sit down with him and explain the whole Medicare Part D process. 3. Refer him to the Medicare specialist in his insurance plan to explain the benefit to him. 4. Request his son come to the next appointment so you can explain the benefit to him. 11. The “donut hole” in Medicare Part D: 1. Will be totally eliminated with the federal health-care reform enacted in 2010 2. Refers to the period of time when annual individual drug costs are between $250 and $2,250 per year and drug costs are covered 75% 3. Refers to the period between when the annual individual drug costs are $2,970 and $4,750 and the patient pays 52.5% of the costs of brand name drugs (2013) 4. Has no effect on whether patients continue to fill their prescriptions during the coverage gap 12. Research has shown that when patients who are covered by Medicare Part D reach the “donut hole” in coverage they: 1. Ask for extra refills of medication to get them through the months of no coverage 2. Fill their prescriptions less frequently, including critical medications such as warfarin or a statin 3. Fill their critical medications, but hold off on filling less-critical medications 4. Demonstrate no change in their prescription filling pattern Chapter 6. Pharmacoeconomics Answer Section MULTIPLE CHOICE 1. ANS: 3 PTS: 1 2. ANS: 3 PTS: 1 3. ANS: 4 PTS: 1 4. ANS: 2 PTS: 1 5. ANS: 1 PTS: 1 6. ANS: 1 PTS: 1 7. ANS: 4 PTS: 1 8. ANS: 3 PTS: 1 9. ANS: 2 PTS: 1 10. ANS: 3 PTS: 1 11. ANS: 3 PTS: 1 12. ANS: 2 PTS: 1 Chapter 7. Nutrition and Nutraceuticals Multiple Choice Identify the choice that best completes the statement or answers the question. 1. The most frequent type of drug-food interaction is food: 1. Causing increased therapeutic drug levels 2. Affecting the metabolism of the drug 3. Altering the volume of distribution of drugs 4. Affecting the gastrointestinal absorption of drugs 2. Food in the gastrointestinal tract affects drug absorption by: 1. Altering the pH of the colon, which decreases absorption 2. Competing with the drug for plasma proteins 3. Altering gastric emptying time 4. Altering the pH of urine 3. Food can alter the pH of the stomach, leading to: 1. Enhanced drug metabolism 2. Altered vitamin K absorption 3. Increased vitamin D absorption 4. Altered drug bioavailability 4. Fasting for an extended period can: 1. Increase drug absorption due to lack of competition between food and the drug 2. Alter the pH of the gastrointestinal tract, affecting absorption 3. Cause vasoconstriction, leading to decreased drug absorption 4. Shrink the stomach, causing decreased surface area for drug absorption 5. Tetracycline needs to be given on an empty stomach because it chelates with: 1. Calcium 2. Magnesium 3. Iron 4. All of the above 6. A low-carbohydrate, high-protein diet may: 1. Increase drug-metabolizing enzymes 2. Decrease drug absorption from the GI tract 3. Alter drug binding to plasma proteins 4. Enhance drug elimination 7. Grapefruit juice contains furanocoumarins that have been found to: 1. Alter absorption of drugs through competition for binding sites 2. Inhibit CYP 3A4, leading to decreased first-pass metabolism of drugs 3. Alter vitamin K metabolism, leading to prolonged bleeding 4. Enhance absorption of calcium and vitamin D 8. Cruciferous vegetables may alter drug pharmacokinetics by: 1. Enhancing absorption of weakly acidic drugs 2. Altering CYP 3A4 activity, leading to elevated levels of drugs, such as the statins 3. Inducing CYP 1A2, possibly leading to therapeutic failure of drugs metabolized by CYP 1A2 4. Decreasing first-pass metabolism of drugs 9. Milk and other foods that alkalinize the urine may: 1. Result in basic drugs being reabsorbed in the renal tubule 2. Increase the elimination of basic drugs in the urine 3. Decrease the elimination of acidic drugs 4. Not alter drug elimination due to the minimal change in urine pH 10. Antacids such as calcium carbonate (Tums) can reduce the absorption of which of the following nutrients? 1. Protein 2. Calcium 3. Iron 4. Vitamin K 11. Phenytoin decreases folic acid absorption by: 1. Altering the pH of the stomach 2. Increasing gastric emptying time 3. Inhibiting intestinal enzymes required for folic acid absorption 4. Chelation of the folic acid into inactive ingredients 12. Patients taking warfarin need to be educated about the vitamin K content of foods to avoid therapeutic failure. Foods high in vitamin K that should be limited to no more than one serving per day include: 1. Spinach 2. Milk 3. Romaine lettuce 4. Cauliflower 13. The American Dietetic Association has recommended the use of specific nutritional supplements in the following population(s): 1. 400 IU per day of vitamin D in all infants and children 2. 1,000 IU per day of vitamin D for all pregnant women 3. 60 mg per day of iron for all adults over age 50 years 4. All of the above 14. The American Dietetic Association recommends pregnant women take a supplement including: 1. 1,000 IU daily of vitamin D 2. 2.4 mcg/day of vitamin B12 3. 600 mcg/day of folic acid 4. 8 mg/day of iron 15. The American Heart Association and the American Dietetic Association recommend a minimum daily fiber intake of for cardiovascular health: 1. 10 mg/day 2. 15 mg/day 3. 20 mg/day 4. 25 mg/day 16. Which of the following vitamin or mineral supplements may by teratogenic if a pregnant woman takes more than the recommended amount? 1. Iron 2. Vitamin A 3. Vitamin B6 4. Vitamin C 17. Vitamin B2 (riboflavin) may be prescribed to: 1. Decrease the incidence of beriberi 2. Reduce headaches and migraines 3. Prevent pernicious anemia 4. Treat hyperlipidemia 18. Isoniazid (INH) may induce a deficiency of which vitamin? 1. B6 2. C 3. D 4. E 19. Pregnant patients who are taking isoniazid (INH) should take 25 mg/day of vitamin B6 (pyridoxine) to prevent: 1. Beriberi 2. Peripheral neuropathy 3. Rickets 4. Megaloblastic anemia 20. Vitamin B12 deficiency may lead to: 1. Hair loss 2. Insomnia 3. Dry scales on the scalp 4. Numbness and tingling of the hands 21. Smokers are at risk for vitamin C deficiency. It is recommended that smokers take vitamin C supplement. 1. 100 mg/day 2. 500 mg/day 3. 1,000 mg/day 4. 35 mg/day more than nonsmokers 22. There is strong evidence to support that adequate vitamin C intake prevents: 1. The common cold 2. Breast cancer 3. Scurvy 4. All of the above 23. Adequate vitamin D is needed for: 1. Absorption of calcium from the gastrointestinal tract 2. Regulation of serum calcium levels 3. Regulation of serum phosphate levels 4. All of the above 24. Newborns are at risk for early vitamin K deficiency bleeding and the American Academy of Pediatrics recommends that all newborns receive: 1. IM vitamin K (phytonadione) within 24 hours of birth 2. Oral vitamin K supplementation in the first 3 weeks of life 3. Formula containing vitamin K or breast milk 4. Oral vitamin K in the first 24 hours after birth 25. Symptoms of folate deficiency include: 1. Thinning of the hair 2. Bruising easily 3. Glossitis 4. Numbness and tingling of the hands and feet 26. A patient with a new onset of systolic ejection murmur should be assessed for which nutritional deficiency? 1. Vitamin B12 2. Vitamin C 3. Folate 4. Niacine 27. According to the National Health and Nutrition Examination Survey study of dietary intake, the group at highest risk for inadequate calcium intake was: 1. The elderly (over age 60 years) 2. Teenage females 3. Teenage males 4. Preschoolers 28. Patients with iron deficiency will develop: 1. Hemolytic anemia 2. Megaloblastic anemia 3. Macrocytic-hypochromic anemia 4. Microcytic-hypochromic anemia 29. There is evidence that dietary supplementation or adequate intake of fish oils and omega-3 fatty acids have well-documented: 1. Concern for developing cardiac dysrhythmias 2. Anti-inflammatory effects 3. Total cholesterol-lowering effects 4. Effects on fasting blood sugar 30. There is enough preliminary evidence to recommend that children with autism receive which supplemental nutrient? 1. Vitamin B1 (thiamine) 2. Vitamin B2 (riboflavin) 3. Calcium 4. Omega-3 fatty acids 31. There is sufficient evidence to support the use of omega-3 fatty acids to treat the following disease(s): 1. Asthma 2. Autism 3. Arthritis 4. All of the above 32. It is reasonable to recommend supplementation with in the treatment of hyperlipidemia. 1. Omega-3 fatty acids 2. Probiotics 3. Plant sterols 4. Calcium 33. Probiotics are recommended to be co-administered when are prescribed: 1. Antacids 2. Antihypertensives 3. Antidiarrheals 4. Antibiotics 34. It is reasonable to add to a Helicobacter pylori treatment regimen to improve eradication rates of H. pylori. 1. Probiotics 2. Omega-3 fatty acids 3. Plant sterols 4. Fiber Chapter 7. Nutrition and Nutraceuticals Answer Section MULTIPLE CHOICE 1. ANS 4 PTS: 1 : 2. ANS 3 PTS: 1 : 3. ANS 4 PTS: 1 : 4. ANS 3 PTS: 1 : 5. ANS 4 PTS: 1 : 6. ANS 1 PTS: 1 : 7. ANS 2 PTS: 1 : 8. ANS 3 PTS: 1 : 9. ANS 1 PTS: 1 : 10. ANS 3 PTS: 1 : 11. ANS 3 PTS: 1 : 12. ANS 1 PTS: 1 : 13. ANS 1 PTS: 1 : 14. ANS 3 PTS: 1 : 15. ANS 4 PTS: 1 : 16. ANS 2 PTS: 1 : 17. ANS 2 PTS: 1 : 18. ANS 1 PTS: 1 : 19. ANS 2 PTS: 1 : 20. ANS 4 PTS: 1 : 21. ANS 4 PTS: 1 : 22. ANS 3 PTS: 1 : 23. ANS 4 PTS: 1 : 24. ANS 1 PTS: 1 : 25. ANS 3 PTS: 1 : 26. ANS 3 PTS: 1 : 27. ANS 2 PTS: 1 : 28. ANS 4 PTS: 1 : 29. ANS 2 PTS: 1 : 30. ANS 4 PTS: 1 : 31. ANS 2 PTS: 1 : 32. ANS 3 PTS: 1 : 33. ANS 4 PTS: 1 34. : ANS 1 PTS: 1 : Chapter 8. Herbal Therapy and Nutritional Supplements Multiple Choice Identify the choice that best completes the statement or answers the question. 1. A good history of herb and supplement use is critical before prescribing because approximately % of patients in the United States are using herbal products. 1. 10 2. 5 3. 38 4. 70 2. A potential harmful effect on patients who take some herbal medication is: 1. Constipation 2. Lead poisoning 3. Diarrhea 4. Life-threatening rash 3. A thorough understanding of herbs is critical to patient safety. An example is the use of cinnamon to treat type II diabetes. It is important the patient uses Ceylon cinnamon, as the commercially available cassia cinnamon contains: 1. Coumadin, which may lead to bleeding problems 2. Coumarin, which can cause liver and kidney damage 3. Cinnamic aldehyde, which is toxic to the kidney 4. Cinnamate eugenol, which is toxic to the liver 4. Traditional Chinese medicine utilizes yin (cooling) versus yang (warming) in assessing and treating disease. Menopause is considered a time of imbalance, therefore the Chinese herbalist would prescribe: 1. Herbs which are yang in nature 2. Herbs that are yin in nature 3. Ginger 4. Golden seal 5. According to traditional Chinese medicine, if a person who has a fever is given a herb that is yang in nature, such as golden seal, the patient’s illness will: 1. Get worse 2. Get better 3. Not be adequately treated 4. Need additional herbs to treat the yang 6. In Ayurvedic medicine, treatment is based on the patient’s dominant dosha, which is referred to as the person’s: 1. Vata 2. Pitta 3. Kapha 4. Prakriti 7. Herbs and supplements are regulated by the U.S. Food and Drug Administration. 1. True 2. False 8. When melatonin is used to induce sleep, the recommendation is that the patient: 1. Take 10 mg 30 minutes before bed nightly 2. Take 1 to 5 mg 30 minutes before bed nightly 3. Not take melatonin more than three nights a week 4. Combine melatonin with zolpidem (Ambien) for the greatest impact on sleep 9. Valerian tea causes relaxation and can be used to help a patient fall asleep. Overdosage of valerian (more than 2.5 gm/dose) may lead to: 1. Cardiac disturbances 2. Central nervous system depression 3. Respiratory depression 4. Skin rashes 10. The standard dosage of St John’s wort for the treatment of mild depression is: 1. 300 mg daily 2. 100 mg three times a day 3. 300 mg three times a day 4. 600 mg three times a day 11. Patients need to be instructed regarding the drug interactions with St John’s wort, including: 1. MAO inhibitors 2. Serotonin reuptake inhibitors 3. Over-the-counter cough and cold medications 4. All of the above 12. Ginseng, which is taken to assist with memory, may potentiate: 1. Aricept 2. Insulin 3. Digoxin 4. Propranolol 13. Licorice root is a common treatment for dyspepsia. Drug interactions with licorice include: 1. Antihypertensives, diuretics, and digoxin 2. Antidiarrheals, antihistamines, and omeprazole 3. Penicillin antibiotic class and benzodiazepines 4. None of the above 14. Patients should be warned about the overuse of topical wintergreen oil to treat muscle strains, as overapplication can lead to: 1. Respiratory depression 2. Cardiac disturbance 3. Salicylates poisoning 4. Life-threatening rashes 15. The role of the NP in the use of herbal medication is to: 1. Maintain competence in the prescribing of common herbal remedies 2. Recommend common over-the-counter herbs to patients 3. Educate patients and guide them to appropriate sources of care 4. Encourage patients to not use herbal therapy due to the documented dangers Chapter 8, Herbal Therapy and Nutritional Supplements Answer Section MULTIPLE CHOICE 1. ANS: 3 PTS: 1 2. ANS: 2 PTS: 1 3. ANS: 2 PTS: 1 4. ANS: 2 PTS: 1 5. ANS: 1 PTS: 1 6. ANS: 4 PTS: 1 7. ANS: 2 PTS: 1 8. ANS: 3 PTS: 1 9. ANS: 1 PTS: 1 10. ANS: 3 PTS: 1 11. ANS: 4 PTS: 1 12. ANS: 2 PTS: 1 13. ANS: 1 PTS: 1 14. ANS: 3 PTS: 1 15. ANS: 3 PTS: 1